NCT06995534 Splinting vs Exercise in De Quervain's Tenosynovitis
| NCT ID | NCT06995534 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Konya Beyhekim Training and Research Hospital |
| Condition | Splints |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-05-29 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-05-29 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
De Quervain's disease is a painful tenosynovitis of the abductor pollicis longus and extensor pollicis brevis muscle tendons located in the first dorsal compartment. The primary treatment for De Quervain's disease is conservative; surgical intervention is rarely required. Currently, there is no standardized treatment protocol supported by strong, up-to-date evidence. The aim of this study is to compare the effectiveness of a static hand-wrist resting splint and exercise therapy in the conservative treatment of De Quervain's tenosynovitis. Patients will be evaluated in terms of pain levels, functional/symptom status, hand-finger strength, pressure pain threshold (PPT), tendon cross-sectional area measured by ultrasound, and the presence of effusion findings (semiquantitative; 0-3), and patient satisfaction.
Eligibility Criteria
Inclusion Criteria: * Adults aged between 18 and 65 years Patients experiencing wrist pain and tenderness for less than 3 months and clinically diagnosed with acute or subacute De Quervain's tenosynovitis Visual Analog Scale (VAS) pain score ≥ 3 Exclusion Criteria: * History of trauma Wrist fractures Local infection Presence of rheumatologic diseases (e.g., rheumatoid arthritis, psoriatic arthritis) Presence of symptomatic hand osteoarthritis Continuous use of nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids Receipt of physical therapy for the hand or wrist within the past 3 months Corticosteroid injection into the hand or wrist within the past 3 months Diagnosed with significant neurological disorders (e.g., upper motor neuron disease) Presence of uncontrolled systemic diseases (e.g., uncontrolled diabetes mellitus, congestive heart failure, chronic kidney disease, hepatic failure) Major psychiatric disorders Communication difficulties
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06995534 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Splints. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06995534 currently recruiting?
Yes, NCT06995534 is actively recruiting participants. Contact the research team at ade.1997.lanu@gmail.com for enrollment information.
Where is the NCT06995534 trial being conducted?
This trial is being conducted at Konya, Turkey (Türkiye).
Who is sponsoring the NCT06995534 clinical trial?
NCT06995534 is sponsored by Konya Beyhekim Training and Research Hospital. The trial plans to enroll 40 participants.